Comparison of interferon monotherapy with interferon-lamivudine combination treatment in children with chronic hepatitis B.

AIM To compare interferon monotherapy with combination treatment using interferon and lamivudine in children with chronic hepatitis B. METHODS Data from 65 children who had received either interferon-alpha (5 MU/m2 subcutaneous thrice a week for 6 months; n=35; Group 1) or this dose of interferon-alpha for 6 months with oral lamivudine for one year (4 mg/Kg/day, maximum 100 mg/day; n=30; Group 2) were analyzed retrospectively. Complete response was defined as ALT normalization, HBeAg/anti-HBe seroconversion and HBV DNA clearance. RESULTS ALT normalization rates were similar in Groups 1 and 2 at the end of interferon treatment (13 [38%] and 16 [52%], respectively), at 12 months (19 [56%] and 18 [58%]) and at 24 months (24 [71%] and 23 [74%]). HBV DNA clearance was more frequently observed at 6 months in Group 2 than in Group 1 (19 [63%] versus 7 [20%]; p=0.01), but not at 12 months (19 [63%] versus 17 [49%]) or at 24 months (20 [67%] versus 21 [60%]). Rate of HBeAg/anti-HBe seroconversion was higher in Group 2 at 12 months (18 [60%] versus 11 [31%]; p< 0.05). Rate of complete response was similar in Groups 1 and 2 at 6 months (5 [14%] and 10 [33%], respectively), 12 months (14 [40%] and 17 [57%]) and 24 months (20 [57%] and 19 [63%]). CONCLUSION Although lamivudine and interferon combination achieved higher initial rates of HBV DNA loss and HBeAg/anti-HBe seroconversion than interferon alone, the final response rates were similar with the two treatments. The combination treatment is therefore not indicated for chronic hepatitis B in children.

[1]  S. Aydoğdu,et al.  Effect of Long-Term Lamivudine in Chronic Hepatitis B Virus-Infected Children , 2003, Antiviral therapy.

[2]  A. Kansu,et al.  Current therapeutic approaches in childhood chronic hepatitis B infection: a multicenter study. , 2003, Journal of gastroenterology and hepatology.

[3]  Man-Fung Yuen,et al.  Viral hepatitis B , 2003, The Lancet.

[4]  Y. Liaw Results of lamivudine trials in Asia. , 2003, Journal of hepatology.

[5]  B. Dikici,et al.  Comparison of treatments of chronic hepatitis B in children with lamivudine and α‐interferon combination and α‐interferon alone , 2002, Pediatrics international : official journal of the Japan Pediatric Society.

[6]  F. Ünal,et al.  Alpha interferon and lamivudine combination therapy for chronic hepatitis B in children , 2002, Pediatrics international : official journal of the Japan Pediatric Society.

[7]  G. Usluer,et al.  Comparison of Different Treatment Combinations for Chronic Hepatitis B Infection , 2002, Journal of chemotherapy.

[8]  E. Sokal Drug Treatment of Pediatric Chronic Hepatitis B , 2002, Paediatric drugs.

[9]  B. Dikici,et al.  Lamivudine and interferon-alpha combination treatment of childhood patients with chronic hepatitis B infection. , 2001, The Pediatric infectious disease journal.

[10]  G. Barbarini,et al.  Long-term efficacy of interferon alpha-2b and lamivudine in combination compared to lamivudine monotherapy in patients with chronic hepatitis B. An Italian multicenter, randomized trial. , 2001, Journal of hepatology.

[11]  S. Schalm Lamivudine-interferon combination therapy for chronic hepatitis B: further support but no conclusive evidence. , 2001, Journal of hepatology.

[12]  N. Leung,et al.  Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: Results after 3 years of therapy , 2001, Hepatology.

[13]  D. Pillay,et al.  Additive antiviral effects of lamivudine and alpha-interferon in chronic hepatitis B infection. , 2000, Antiviral therapy.

[14]  J. Hoofnagle,et al.  Long‐term therapy of chronic hepatitis B with lamivudine , 2000, Hepatology.

[15]  Y. Liaw,et al.  Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. , 2000, Gastroenterology.

[16]  C. Chu,et al.  Clearance of the original hepatitis B virus YMDD‐motif mutants with emergence of distinct lamivudine‐resistant mutants during prolonged lamivudine therapy , 2000, Hepatology.

[17]  Ally,et al.  A ONE-YEAR TRIAL OF LAMIVUDINE FOR CHRONIC HEPATITIS B , 2000 .

[18]  E. Schiff,et al.  Lamivudine as initial treatment for chronic hepatitis B in the United States. , 1999, The New England journal of medicine.

[19]  N. Leung,et al.  A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. , 1998, The New England journal of medicine.

[20]  J. Sarles,et al.  Interferon alfa therapy for chronic hepatitis B in children: a multinational randomized controlled trial. , 1998, Gastroenterology.

[21]  D. Torre,et al.  Interferon-α Therapy for Chronic Hepatitis B in Children: A Meta-Analysis , 1996 .

[22]  D. Torre,et al.  Interferon-alpha therapy for chronic hepatitis B in children: a meta-analysis. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  J. Bartolomé,et al.  Factors predictive of response to interferon therapy in children with chronic hepatitis B. , 1995, Journal of hepatology.

[24]  J. de Groote,et al.  [Classification of chronic hepatitis]. , 1968, Deutsche medizinische Wochenschrift.